BioReference declares strategic purchase of Edge BioSystem

August 21
10:19 PM 2013

BioReference Laboratories, Inc shared that they have entered into a definitive agreement with Edge Biosystems CLIA, a genetic sequencing service located in Gaithersburg.

GeneDx, BRLI's own clinical diagnostic sequencing laboratory, will take over Edge BioServe genetic sequencing services. The purchase of Edge includes machine and competences that will boost GeneDx services and preserve its status as the foremost provider of clinical genetic sequencing services. GeneDx also trusts that the purchase of Edge BioSystems will cultivate their services further through the added apparatus and infrastructure from Edge BioSystems. 

BioReference Laboratories, Inc is a firm that presents services for clinical testing, data and related services to medical physician, clinics, hospitals and offices. The laboratory is the fourth-largest in the U.S. when it comes to full servicing.  It is also the main self-regulating regional laboratory in the Northeastern market. It offers a complete list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of disease.

© 2023 VCPOST, All rights reserved. Do not reproduce without permission.


Join the Conversation

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics